The Ehrlich Group has filed approximately 30 patent applications for coronavirus-related technologies, on behalf of dozens of Israeli entrepreneurs.
By Adv. & Patent Attorney Roy Melzer, Head of Software, Information Sys. Department The European patent office (EPO) recently published its revised guidelines for examination. The new guidelines include a new section that specifically addresses Artificial intelligence (AI) and machine learning inventions, which are defined as computational models and algorithms for classification, clustering, regression and …
By: Dr. Jacob Blumenthal and Maier Fenster, Ehrlich & Fenster of Ehrlich Group. A few days ago I received an e-mail from one of our clients saying ” Dear Jacob, we are about to present our clinical study results in two weeks from today. Will that affect our intellectual property protection?”. Of course it will. Many …
By Adv. Yehuda Neubauer, Partner, Ehrlich, Neubauer & Melzer of Ehrlich Group. In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. dated January 22, 2019, The United States Supreme Court unanimously held that the sale of an invention to a party that is obligated to keep the invention confidential may be considered “on sale” for the …
The Israel Patent Office recently published its 2017 Annual Report, which reflects the state of IP prosecution in Israel regarding the submission and examination of patent, trademark and design applications. The report reveals interesting trends and changes in the IP registration system in Israel.